Analysis of 462 Transplantations from Unrelated Donors Facilitated by the National Marrow Donor Program

Keyphrases

• Transplantation 100%
• Unrelated Donor 100%
• National Marrow Donor Program 100%
• Marrow 60%
• Marrow Transplant 60%
• Allogeneic 40%
• Disease-free Survival 40%
• Family Members 40%
• Marrow Transplantation 40%
• HLA-matched Donor 40%
• Metabolic Disease 40%
• Hematological Cancer 40%
• Patient numbers 40%
• Chronic Graft-versus-host Disease (cGVHD) 40%
• Lymphohematopoietic 40%
• United States 20%
• Congenital Disorders 20%
• High Risk 20%
• Leukemia 20%
• Prognostic Factors 20%
• Bone Marrow Failure 20%
• Engraftment 20%
• Donor Pool 20%
• Treatment Type 20%
• Allogeneic Bone Marrow Transplantation 20%
• Living Donor 20%
• Immunodeficiency Diseases 20%
• HLA Matching 20%
• Survival Probability 20%
• Myelodysplasia 20%
• Aplastic Anemia 20%
• HLA-identical Sibling 20%
• HLA-identical 20%
• Marrow Failure 20%
• Cancer Syndrome 20%
• Secondary Graft Failure 20%

Medicine and Dentistry

• Disease Free Survival 100%
• Water-Electrolyte Imbalance 100%
• Congenital Disorder 50%
• Cancer 50%
• Graft Failure 50%
• Immune Deficiency 50%
• Patient with Leukemia 50%
• Prognostic Factor 50%
• Bone Marrow Failure 50%
• Engraftment 50%
• Aplastic Anemia 50%
• Allogenic Bone Marrow Transplantation 50%
• Myelodysplastic Syndrome 50%
• Chronic Graft Versus Host Disease 50%
• Acute Graft Versus Host Disease 50%
• Cancer Syndrome 50%

Immunology and Microbiology

• Disease Free Survival 100%
• Engraftment 50%
• Aplastic Anemia 50%
• Immunodeficiency 50%
• Chronic Graft Versus Host Disease 50%
• Acute Graft Versus Host Disease 50%
• Allogeneic Bone Marrow Transplantation 50%